BENSALEM, Pa.--(BUSINESS WIRE)--
Law Offices of Howard G. Smith announces an investigation on behalf of Corcept Therapeutics Incorporated investors (“Corcept” or the “Company”) (NASDAQ: CORT) concerning the Company and its officers’ possible violations of federal securities laws.
On January 25, 2019, Southern Investigative Reporting Foundation (SIRF) published a report alleging that Corcept paid doctors to prescribe its drug Korlym for off-label uses in 2016 - 2017. The report condemned the company for exploiting regulatory loopholes, charging patients an excessive price for its lone drug product, and touting evidence for the drug's effectiveness that -- according to SIRF – doesn't exist." On this news, shares of Corcept fell $1.52 or 11%, to close at $12.29 on January 25, 2019, thereby injuring investors.
If you purchased Corcept securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.